# Oncology Treatment Related Ocular Surface Changes

> **NCT07666724** · — · COMPLETED · sponsor: **Semmelweis University** · enrollment: 35 (actual)

## Conditions studied

- Breast Neoplasm, Exercise

## Interventions

- **DRUG:** Trastuzumab (Herceptin)

## Key facts

- **NCT ID:** NCT07666724
- **Lead sponsor:** Semmelweis University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-18
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07666724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07666724, "Oncology Treatment Related Ocular Surface Changes". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07666724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*